Superantigens: microbial agents that corrupt immunity

被引:210
作者
Llewelyn, M
Cohen, J
机构
[1] Hammersmith Hosp, Dept Infect Dis, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London SW7 2AZ, England
关键词
D O I
10.1016/S1473-3099(02)00222-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Microbial superantigens are a family of protein exotoxins that share the ability to trigger excessive and aberrant activation of T cells. The best characterised are the staphylococcal enterotoxins and the streptococcal pyrogenic exotoxins that trigger the staphylococcal and streptococcal toxic shock syndromes. It is now apparent that superantigens have a wider role in the pathology of infectious diseases than has previously been appreciated. Staphylococcus aureus and Streptococcus pyogenes together produce 19 different superantigens. The range of microorganisms known to produce superantigens has expanded to include Gram negative bacteria, mycoplasma, and viruses. Research is beginning to shed light on the more subtle parts these molecules play in causing disease and to produce some real possibilities for specific treatment of superantigen-induced toxicity. We aim to highlight these new developments and review the science behind these fascinating molecules.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 62 条
  • [51] Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals
    Schlievert, PM
    Jablonski, LM
    Roggiani, M
    Sadler, I
    Callantine, S
    Mitchell, DT
    Ohlendorf, DH
    Bohach, GA
    [J]. INFECTION AND IMMUNITY, 2000, 68 (06) : 3630 - 3634
  • [52] Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes
    Sriskandan, S
    Unnikrishnan, M
    Krausz, T
    Cohen, J
    [J]. MOLECULAR MICROBIOLOGY, 1999, 33 (04) : 778 - 790
  • [53] Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes
    Sriskandan, S
    McKee, A
    Hall, L
    Cohen, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) : 275 - 277
  • [54] The toxic shock syndromes
    Stevens, DL
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1996, 10 (04) : 727 - +
  • [55] SEVERE GROUP-A STREPTOCOCCAL INFECTIONS ASSOCIATED WITH A TOXIC SHOCK LIKE SYNDROME AND SCARLET FEVER TOXIN-A
    STEVENS, DL
    TANNER, MH
    WINSHIP, J
    SWARTS, R
    RIES, KM
    SCHLIEVERT, PM
    KAPLAN, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (01) : 1 - 7
  • [56] INVASIVE GROUP A STREPTOCOCCUS INFECTIONS
    STEVENS, DL
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) : 2 - 13
  • [57] Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen
    Sutkowski, N
    Conrad, B
    Thorley-Lawson, DA
    Huber, BT
    [J]. IMMUNITY, 2001, 15 (04) : 579 - 589
  • [58] Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen
    Takahashi, N
    Kato, H
    Imanishi, K
    Miwa, K
    Yamanami, S
    Nishida, H
    Uchiyama, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) : 1409 - 1415
  • [59] Bacterial superantigens in human disease: Structure, function and diversity
    Ulrich, RG
    Bavari, S
    Olson, MA
    [J]. TRENDS IN MICROBIOLOGY, 1995, 3 (12) : 463 - 468
  • [60] Inhibition of bacterial superantigens by peptides and antibodies
    Visvanathan, K
    Charles, A
    Bannan, J
    Pugach, P
    Kashfi, K
    Zabriskie, JB
    [J]. INFECTION AND IMMUNITY, 2001, 69 (02) : 875 - 884